PBRM1 and nonpapillary renal cell carcinoma: Genomic copy number is varied across these RTKs and downstream pathways, indicating that the genomic CNVs in RTKs and downstream signaling transduction pathways may have important roles in the pathogenesis and progression of the VHL/PBRM1-negative ccRCC.